Open AccessAnalysis of Gynecologic Cancer Management at Sanglah Hospital during COVID- 19 Pandemic
Author(s) -
I Gde Sastra Winata,
Ngakan Ketut Darmawan,
I Nyoman Gede Budiana,
I Nyoman Bayu Mahendra
Publication year - 2022
Publication title -
european journal of medical and health sciences
Language(s) - English
Resource type - Journals
ISSN - 2593-8339
DOI - 10.24018/ejmed.2022.4.2.1283
Subject(s) - pandemic , medicine , covid-19 , radiation therapy , gynecologic cancer , cancer , chemotherapy , disease , intensive care medicine , oncology , surgery , ovarian cancer , infectious disease (medical specialty)
The COVID-19 pandemic presents its own challenges in treating cancer, especially gynecological cancer. The condition of cancer patients who have been immunocompromised either because of their disease or side effects of the drugs given, has the potential to increase the risk of cancer patients to experience severe COVID-19 infection. The main management of cancer, which is based on three axes, namely surgery, chemotherapy, and radiotherapy, needs to be adapted to increase survival rates. rates in patients.